DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo


company name or ticker

Benzinga's Volume Movers

Today's Market: Hepatitis C News Moving These Stocks

U.S. Stocks Set to Mostly Continue Post-Fed Rally in Light Holiday Trading; Chicago Fed Activity Ind

U.S. Stocks Set to Mostly Continue Post-Fed Rally in Light Holiday Trading; Chicago Fed Activity Index Surges

Six Biotech and Technology Stocks With Strong Technical Set-Ups

3 Traits of the Best Healthcare Stocks in 2014

The best healthcare stocks in 2014 saw their shares gain as much as 400% because they exhibited at least one of the following three key traits.

Sovaldi Can't Sustain The Current Prices Of Gilead Sciences' Stock: Algorithmic And Fundamental Anal

Sovaldi Can't Sustain The Current Prices Of Gilead Sciences' Stock: Algorithmic And Fundamental Analysis

January 2015 Options Now Available For Achillion Pharmaceuticals (ACHN)

Why Gilead Sciences and AbbVie Care About This Tiny Company

Achillion Pharmaceuticals is conducting a study that could reduce hepatitis C treatment to six weeks.

These 4 Biotech Stocks Have Been On Fire

December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey

See More Articles...